During thioacetamide-induced acute liver failure, the proliferative response of hepatocytes to thyroid hormone is maintained, indicating a potential therapeutic approach to toxin-induced liver disease

Digestive Diseases and Sciences

Volumn 51, Issue 12, 2006, Pages 2235-2241

  Malik, Raza ^a   Saich, Rebecca ^a   Rahman, Tony ^a   Hodgson, Humphrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Acute hepatic failure; Primary mitogen; T3; Thioacetamide; Thyroid hormone

Indexed keywords

LIOTHYRONINE; MITOGENIC AGENT; THIOACETAMIDE;

ANIMAL; ARTICLE; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; LIVER CELL; LIVER FAILURE; LIVER REGENERATION; MALE; PATHOLOGY; RANDOMIZATION; RAT;

ANIMALS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; LIVER FAILURE, ACUTE; LIVER REGENERATION; MALE; MITOGENS; RANDOM ALLOCATION; RATS; THIOACETAMIDE; TRIIODOTHYRONINE;

EID: 33846955463     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-006-9275-1     Document Type: Article

References (24)

1. Columbano A, Shinozuka H (1996) Liver regeneration versus direct hyperplasia. FASEB J 10(10):1118-1128
2. Malik R, Selden C, Hodgson H (2002) The Role of nonparenchymal cells in liver growth. Semin Cell Dev Biol 13(6):425-431
3. Ohmura T, Ledda-Columbano GM, Piga R, et al. (1996) Hepatocyte proliferation induced by a single dose of a peroxisome proliferator. Am J Pathol 148(3):815-824
4. Columbano A, Ledda-Columbano GM, Pibii M, et al. (1997) Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP. Oncogene 14(7):857-863
5. Francavilla A, Carr B, Azzarone, et al. (1994) Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro. Hepatology 20(5):1237-1241
6. Malik R,Mellor N, Selden C, Hodgson H (2003) Triiodothyronine enhances the regenerative capacity of the liver following partial hepatectomy. Hepatology 37(1):79-86
7. Alison MR (1986) Regulation of hepatic growth. Physiol Rev 66(3):499-541
8. Ledda-Columbano GM, Coni P, CurtoM, et al. (1991) Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am J Pathol 139(5):1099-1109
9. Margeli AP, Skaltsas SD, Spiliopoulou CA, Mykoniatis MG, Theocharis SE (1999) Hepatic stimulator substance activity in the liver of thioacetamide-intoxicated rats. Liver 19(6):519-525
10. Rahman TM, Hodgson HJ (2003) The effects of early and late administration of inhibitors of inducible nitric oxide synthase in a thioacetamide-induced model of acute hepatic failure in the rat. J Hepatol 38(5):583-590
11. Riordan SM,Williams R (2003) Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis 23(3):203-215
12. Lemire JM, Shiojiri N, Fausto N (1991) Oval cell proliferation and the origin of small hepatocytes in liver injury induced by Dgalactosamine. Am J Pathol 139(3):535-552
13. Ghoshal AK, Mullen B, Medline A, Farber E (1983) Sequential analysis of hepatic carcinogenesis. Regeneration of liver after carbon tetrachloride-induced liver necrosis when hepatocyte proliferation is inhibited by 2-acetylaminofluorene. Lab Invest 48(2):224-230
14. Rahman TM, Hodgson HJ (2000) Animal models of acute hepatic failure. Int J Exp Pathol 81(2):145-157
15. Hui TT, Mizuguchi T, Sugiyama N, Avital I, Rozga J, Demetriou A (2002) Immediate early genes and P21 regulation in liver of rats with acute hepatic failure. Am J Surg 183(4):457-463
16. Mizuguchi T, Kamohara Y, Hui T, et al. (2001) Regulation of c-met expression in rats with acute hepatic failure. J Surg Res 99(2):385-396
17. Shiota G, Okano J,Umeki K, Kawasaki H, Kawamoto T, Nakamura T (1994) Serum hepatocyte growth factor in acute hepatic failure in comparison with acute hepatitis. Res Commun Mol Pathol Pharmacol 85(2):157-162
18. Michalopoulos GK, DeFrancesMC(1997) Liver regeneration. Science 276(5309):60-66
19. Zandieh Doulabi B, Platvoet-ter Schiphorst M, van Beeren HC, et al. (2002) TR(beta)1 protein is preferentially expressed in the pericentral zone of rat liver and exhibits marked diurnal variation. Endocrinology 143(3):979-984
20. Bruck R, Oren R, Shirin H, et al. (1998) Hypothyroidism minimizes liver damage and improves survival in rats with thioacetamide induced fulminant hepatic failure. Hepatology 27(4):1013-1020
21. Harrison PM, Hughes RD, Forbes A, Portmann B, Alexander GJ, Williams R (1990) Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure. J Hepatol 10(3):332-336
22. Hwang TH,Yoon BC, Jeong JS, SeoSY, Lee HJ (2003)Asingle administration of adenoviral-mediated HGF cDNA permits survival of mice from acute hepatic failure. Life Sci 72(7):851-861
23. Margeli AP, Manolis E, Skaltsas SN, Tsarpalis KS, Mykoniatis MG, Theocharis SE (2002) Hepatic stimulator substance activity in animal model of fulminant hepatic failure and encephalopathy. Dig Dis Sci 47(10):2170-2178
24. Salim A, Vassiliu P, Velmahos GC, et al. (2001) The role of thyroid hormone administration in potential organ donors. Arch Surg 136(12):1377-13780